Description:
PHENYLKETONURIA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Amino Acid Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.23 |
Passage Frozen |
4 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
Gene |
PAH |
Chromosomal Location |
12q24.1 |
Allelic Variant 1 |
261600.0031; PHENYLKETONURIA |
Identified Mutation |
PHE39LEU; See Forrest et al. (1991).
|
|
Gene |
PAH |
Chromosomal Location |
12q24.1 |
Allelic Variant 2 |
; PHENYLKETONURIA |
Identified Mutation |
IVS10-11G>A |
Remarks |
Clinically affected; normal level of dihydropteridine reductase in skin fibroblasts; donor subject is a compound heterozygote: one allele has a C>G transversion at nucleotide 117 in exon 2 of the PAH gene [117C>G] resulting in a substitution of leucine for phenylalanine at codon 39 [Phe39Leu (F39L)] and a second allele has a splice site mutation at nucleotide 1066 [IVS10-11G>A]. |
Veleva D, Ay M, Ovchinnikov DA, Prowse ABJ, Menezes MJ, Nafisinia M, Generation of fibroblast-derived induced pluripotent stem cell (iPSC) lines from two paediatric patients with phenylketonuria Stem cell research77:103405 2024 |
PubMed ID: 38555716 |
|
Veleva D, Ay M, Ovchinnikov DA, Prowse ABJ, Menezes MJ, Nafisinia M, Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria Stem cell research77:103407 2024 |
PubMed ID: 38552357 |
Passage Frozen |
4 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|